| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Hims & Hers Health, Inc. (HIMS) has 15 insiders with recent SEC Form 4 filings, including 0 buys and 22 sells. HIMS is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 460.9K | $15.07M | - | |
| COO | 432.1K | $14.13M | -14,027 | |
| Other | 176.4K | $5.77M | - | |
| CFO | 160.9K | $5.26M | - | |
| Other | 141.1K | $4.61M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 20, 2024 | Okupe Oluyemi55 | Chief Financial Officer | Sell | 9,912 | $15.82 | $156,816.43 | -1.9% | +50.4% | +99.5% | |
| Mar 19, 2024 | O'Keefe Lynne Chou | Director | Sale+OE | 10,044 | $15.52 | $155,882.88 | -100% | +54.4% | +116.6% | |
| Mar 19, 2024 | Becklund Irene | Pao | Sale+OE | 13,825 | $15.49 | $214,176.96 | -50.9% | +54.4% | +116.6% | |
| Mar 13, 2024 | Boughton Soleil | Chief Legal Officer | Sale+OE | 63,621 | $15.17 | $965,016.05 | -29.2% | +45.8% | +108.6% | |
| Mar 7, 2024 | Baird Melissa | Chief Operating Officer | Sale+OE | 35,253 | $14.19 | $500,106.61 | -1.1% | +51.6% | +150.5% | |
| Mar 7, 2024 | Becklund Irene | Pao | Sell | 2,747 | $14.19 | $38,979.93 | -100% | +51.6% | +150.5% | |
| Mar 4, 2024 | Okupe Oluyemi55 | Chief Financial Officer | Sale+OE | 50,574 | $13.55 | $685,287.60 | -8.7% | +39.4% | +175.4% | |
| Mar 4, 2024 | Becklund Irene | Pao | Sale+OE | 20,677 | $14.32 | $296,135.52 | -79.0% | +39.4% | +175.4% | |
| Mar 1, 2024 | Dudum Andrew48 | Chief Executive Officer | Sale+OE | 384,997 | $13.07 | $5,032,141.79 | -19.4% | +55.3% | +243.7% | |
| Feb 29, 2024 | Dudum Andrew48 | Chief Executive Officer | Sale+OE | 577,007 | $12.96 | $7,480,261.05 | -91.8% | +50.2% | +245.8% |